Moving beyond the Site – Risk-based Monitoring at the Patient Level

New York, N.Y. – September 10, 2014 – AiCure, an artificial intelligence company providing advanced facial recognition and motion-sensing solutions to monitor medication adherence, announced that Adam Hanina, Chief Executive Officer, will present at the Risk-based Monitoring in Clinical Studies on November 7, 2014 in Philadelphia. Mr. Hanina will present “Moving beyond the Site – Risk-based Monitoring at the Patient Level” and demonstrate how major biopharmaceutical companies have reduced risk, improved data integrity, and increased the protection of human subjects through AiCure’s platform.